Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postoperative delirium in elderly thoracic surgery patients
ChiCTR2100052750Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Guangzhou Medical University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and dexmedetomidine in postoperative delirium (POD) (3 arms), sponsored by Affiliated Cancer Hospital of Guangzhou Medical University. Primary endpoint: Postoperative delirium. Started Mar 2022; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100052750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052750.